Preservation of Enzyme Activity and Antigenicity after Mutagenesis of the Membrane Anchoring Domain of GAD65

References

• Bach J ‐F. Insulin‐dependent diabetes mellitus as an autoimmune disease. Endocrine Rev 1994; 15: 516–42
   PubMed Web of Science ®Google Scholar
• Hagopian W A, Sanjeevi C B, Kockum I, Landin‐Olsson M, Karlsen A E, Sundkvist G, et al. Glutamate decarboxylase‐, insulin‐and islet cell‐antibodies and HLA typing to detect diabetes in a general population‐based study of Swedish children. J. Clin. Invest 1995; 95: 1505–11
   PubMed Web of Science ®Google Scholar
• Wilkin T, Armitage M, Casey C, Pyke D A, Hoskins P J, Rodier M, et al. Value of insulin autoantibodies as serum markers for insulin‐dependent diabetes mellitus. Lancet 1985; 480–2
   PubMedGoogle Scholar
• Baekkeskov S, Aanstoot H J, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin‐dependent diabetes as the GABA‐synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151–6
   PubMed Web of Science ®Google Scholar
• Verge C F, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson R A, et al. Prediction of type I diabetes in first‐degree relatives using a combination of insulin, GAD, and ICA512bdc/IA‐2 autoantibodies. Diabetes 1996; 45(7)926–33
   PubMed Web of Science ®Google Scholar
• Atkinson M A, Kaufman D L, Campbell L, Gibbs K A, Shah S C, Bu D ‐F, et al. Response of peripheral‐blood mononuclear cells to glutamate decarboxylase in insulin‐dependent diabetes. Lancet 1992; 339: 458–9
   PubMed Web of Science ®Google Scholar
• Atkinson M A, Bowman M A, Campbell L, Darrow B L, Kaufman D L, Maclaren N K. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin‐dependent diabetes. J Clin Invest 1994; 94(5)2125–9
   PubMed Web of Science ®Google Scholar
• Panina‐Bordignon P, Lang R, van Endert P M, Benazzi E, Felix A M, Pastore R M, et al. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J. Exp. Med 1995; 181: 1923–7
   PubMed Web of Science ®Google Scholar
• Lemmark Å, Klöppel G, Stenger D, Vathanaprida C, Fait K, Landin‐Olsson M, et al. Heterogeneity of human islet pathology in newly diagnosed childhood insulin‐dependent diabetes mellitus. Macrophage infiltrations and expression of HLA.‐DQ and glutamic acid decarboxylase. Virchows Archiv 1995; 425: 631–40
   PubMedGoogle Scholar
• Bu D ‐F, Erlander M G, Hitz B C, Tillakaratne N J K, Kaufman D L, Wanger‐McPherson C B, et al. Two human glutamate decarboxylases, 65‐kDa GAD and 67‐kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci 1992; 89: 2115–9
   PubMed Web of Science ®Google Scholar
• Kaufman D J, Erlander M G, Clare‐Salzler M, Atkinson M A, Maclaren N K, Tobin A J. Autoimmunity to two forms of glutamate decarboxylase in Insulin‐dependent diabetes mellitus. J. Clin. Invest 1992; 89: 283–92
   PubMed Web of Science ®Google Scholar
• Hagopian W A, Michelsen B, Karlsen A E, Larsen F, Moody A, Grubin C E, et al. Autoantibodies in IDDM primarily recognize the 65,000‐Mr rather than the 67,000‐Mr isoform of glutamic acid decarboxylase. Diabetes 1993; 42: 631–6
   PubMed Web of Science ®Google Scholar
• Solimena M, Folli F, Denis‐Donini S, Comi G C, Pozza G, De Camilli P, et al. Autoantibodies directed against glutamic acid decarboxylase (GAD) in the cerebrospinal fluid and serum of a patient with Stiff‐Man syndrome, epilepsy and type I diabetes mellitus. N. Engl. J. Med 1988; 318: 1012–20
   PubMed Web of Science ®Google Scholar
• Kim J, Namchuck M, Bugawan T, Fu Q, Jaffe M, Shi Y, et al. Higher autoantibody levels and recognition of a linear NH2‐terminal epitope in the autoantigen GAD65, distinguish Stiff‐Man Syndrome from insulin‐dependent diabetes melli‐tus. J. Exp. Med 1994; 180: 595–606
   PubMed Web of Science ®Google Scholar
• Tuomi T, Bjorses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, et al. Antibodies to glutamic acid decarboxylase and insulin‐dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 1996; 81(4)1488–94
   PubMed Web of Science ®Google Scholar
• Spink D C, Porter T G, Wu S J, Martin D L. Kinetically different, multiple forms of glutamate decarboxylase in rat brain. Brain Res 1987; 421(1–2)235–44
   PubMedGoogle Scholar
• Johnston P A, Cameron P L, Stukenbrok H, Jahn R, De Camilli P, Sudhof T C. Synaptophysin is targeted to similar microvesicles in CHO and PC12 cells. Embo J 1989; 8(10)2863–72
   PubMedGoogle Scholar
• Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P. GABA and pancreatic p‐cells: Co‐localization of glutamic acid decarboxylase (GAD) and GABA with synap‐tic‐like microvesicles suggests their role in GABA storage and secretion. EMBO J 1991; 10: 1275–84
   PubMed Web of Science ®Google Scholar
• Christgau S, Schierbeck H, Aanstoot H ‐J, Aagaard L, Begley K, Kofod H, et al. Pancreatic p cells express two autoanti‐genic forms of glutamic acid decarboxylase, a 65‐kDa hydrophilic form and a 64‐kDa amphiphilic form which can be both membrane‐bound and soluble. J. Biol. Chem 1991; 286: 21257–64
   Google Scholar
• Erlander M G, Tillakaratne N J K, Feldblum S, Patel N, Tobin A J. Two genes encode distinct glutamate decarboxylase. Neuron 1991; 7: 91–100
   PubMed Web of Science ®Google Scholar
• Karlsen A E, Hagopian W A, Grubin C E, Dube S, Disteche C M, Adler D A, et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci US 1991; 88: 8337–4
   PubMed Web of Science ®Google Scholar
• Solimena M, Aggujaro D, Muntzel C, Dirkx R, Butler M, De Camilli P, et al. Association of GAD‐65, but not of GAD‐67, with the Golgi complex of transfected Chinese hamster ovary cells mediated by the N‐terminal region. Proc. Nail. Acad. Sci 1993; 90: 3073–7
   PubMed Web of Science ®Google Scholar
• Kanaani J, Lissin D, Kash S F, Baekkeskov S. The hydrophilic isoform of glutamate decarboxylase, GAD67, is targeted to membranes and nerve terminals independent of dimerization with the hydrophobic membrane‐anchored isoform, GAD65. J Biol Chem 1999; 274(52)37200–9
   PubMedGoogle Scholar
• Richter W, Shi Y, Baekkeskov S. Autoreactive epitopes defined by diabetes‐associated human monoclonal antibodies are localized in the middle and C‐terminal domains of the smaller form of glutamate decarboxylase. Proc. Natl. Acad. Sci. USA 1993; 90: 2832–6
   PubMed Web of Science ®Google Scholar
• Ujihara N, Daw K, Gianani R, Boel E, Yu L, Powers A C. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes. Diabetes 1994; 43(8)968–75
   PubMedGoogle Scholar
• Syren K, Lindsay L, Stoehrer B, Jury K, Luhder F, Baekkeskov S, et al. Immune reactivity of diabetes‐associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol 1996; 157(11)5208–14
   PubMedGoogle Scholar
• Hampe C S, Ortqvist E, Persson B, Schranz D B, Lernmark A. Glutamate decarboxylase (GAD) autoantibody epitope shift during the first year of Type 1 diabetes. Hormone & Metabolic Research 1999; 31(10)553–7
   PubMedGoogle Scholar
• Schwartz H L, Chandonia J M, Kash S F, Kanaani J, Tunnell E, Domingo A, et al. High‐resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 1999; 287(5)983–99
   PubMedGoogle Scholar
• Karlsen A E, Michaelsen B K, Pedersen J K, Hagopian W A, Grubin C E, Boel E, et al. Glutamic acid decarboxylase: An autoantigen in insulin‐dependent diabetes mellitus. Diabetes, Nutr. Metab 1992; 5: 97–103
   Google Scholar
• Falorni A, Örtqvist E, Persson B, Lernmark Å. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Methods 1995; 186: 89–99
   PubMed Web of Science ®Google Scholar
• Li L, Jiang J, Hagopian W A, Karlsen A E, Skelly M, Baskin D G, et al. Differential detection of rat islet and brain glutamic acid decarboxylase (GAD) isoforms with sequence‐specific peptide antibodies. J Histochem Cytochem 1995; 43(1)53–9
   PubMedGoogle Scholar
• Grubin C E, Daniels T, Toivola B, Landin‐Olsson M, Hagopian W A, Li L, et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform‐specific glutamic acid decarboxylase antibodies in childhood I. D. D. M. Diabeto‐logia 1994; 37: 344–50
   PubMed Web of Science ®Google Scholar
• Hampe C, Hammerle L, Bekris L, Ortqvist E, Kockum I, Rolandsson O, et al. Recognition of Glutamic Acid Decarboxylase (GAD) by Autoantibodies from Different GAD Antibody‐Positive Phenotypes. J Clin Endocrinol Metab 2000; 85(12)4671–9
   PubMedGoogle Scholar
• Wu J Y, Denner L, Lin C T, Song G X. L.‐Glutamate decarboxylase from brain. Methods Enzymol 1985; 113: 3–10
   PubMedGoogle Scholar
• Hampe C, Hammerle L, Falorni A, Robertson J, Lernmark A. Site‐Directed Mutagenesis of K396R of the 65 kDa Glutamic Acid Decarboxylase active Site Inhibits Enzyme Activity but not Antibody Binding. FEBS lett 2001, In press
   PubMedGoogle Scholar
• Solimena M, Dirkx R, Jr, Radzynski M, Mudigl O, De Camilli P. A signal located within amino acids 1–27 of GAD65 is required for its targeting to the Golgi complex region. J. Cell Biol 1994; 126: 331–41
   PubMed Web of Science ®Google Scholar
• Shi Y, Veit B, Baekkeskov S. Amino acid residues 24–31 but not Palmitoylation of cysteines 30 and 45 are required for membrane anchoring of glutamic acid decarboxylase, GAD65/. Cell Biol 1994; 124: 927–34
   PubMed Web of Science ®Google Scholar
• Covarrubias M, Tapia R. Calcium‐dependent binding of brain glutamate decarboxylase to phospholipid vesicles. J Neurochem 1978; 31(5)1209–14
   PubMedGoogle Scholar
• Covarrubias M, Tapia R. Brain glutamate decarboxylase: properties of its calcium‐dependent binding to liposomes and kinetics of the bound and the free enzyme. J Neurochem 1980; 34(6)1682–8
   PubMedGoogle Scholar
• Christgau S, Aanstoot H J, Schierbeck H, Begley K, Tullin S, Hejnaes K, et al. Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic p‐cells by palmitoylation in the NH2‐terminal domain. J Cell Biol 1992; 118: 309–20
   PubMed Web of Science ®Google Scholar
• Namchuk M, Lindsay L, Turck C W, Kanaani J, Baekkeskov S. Phosphorylation of serine residues 3, 6, 10 and 13 distinguishes membrane anchored from soluble glutamic acid decarboxylase 65 and is restricted to glutamic acid decarboxylase 65alpha. J Biol Chem 1997; 272(3)1548–57
   PubMedGoogle Scholar
• Plesner A, Lernmark A. Beta Cell Antigens. Endocrine Autoimmunity and Associated Conditions1 ed., A P Weetman. Kluwer Academic Publishers, Dordrecht 1998; 113–144
   Google Scholar
• Brewer J M, Tetley L, Richmond J, Liew F Y, Alexander J. Lipid vesicle size determines the Thl or Th2 response to entrapped antigen. J Immunol 1998; 161(8)4000–7
   PubMedGoogle Scholar
• Ujihara N, Daw K, Gianani R, Boel E, Yu L, Powers A C. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes. Diabetes 1994; 43: 968–75
   PubMed Web of Science ®Google Scholar
• Daw K, Ujihara N, Atkinson M, Powers A C. Glutamic acid decarboxylase autoantibodies in stiff‐man syndrome and insulin‐dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 1996; 156(2)818–25
   PubMed Web of Science ®Google Scholar
• Landin‐Olsson M, Palmer J P, Lernmark Å, Blom L, Sund‐kvist G, Nyström L, et al. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin‐dependent) diabetes mellitus in a population‐based study of newly‐diagnosed diabetic and matched control children. Diabetologia 1992; 35: 1068–73
   PubMed Web of Science ®Google Scholar
• Bingley P J, Bonifacio E, Williams A J, Genovese S, Bottazzo G F, Gale E A. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. DiabetesXWl;, 46(11)1701–10
   Google Scholar
• Hampe C S, Ortqvist E, Rolandsson O, Landin‐Olsson M, Torn C, Agren A, et al. Species‐specific autoantibodies in type 1 diabetes. J Clin Endocrinol Metab 1999; 84(2)643–8
   PubMedGoogle Scholar